RESEARCH NOTE
·
Medadvisor Ltd (MDR)
What should we do with this pharmaceuticals company?
Healthcare
Daily
ASX
This report is available to subscribers
The full research note on Medadvisor Ltd — our view, the levels we are working to and the reasoning behind them — is part of a Kapitales subscription.